Remimazolam attenuates traumatic brain injury-induced acute lung injury by suppressing pulmonary epithelial pyroptosis

Abstract Background and objectives TBI-induced acute lung injury (TBI-ALI), with an incidence rate of 22-25%, represents a critical determinant of secondary mortality. Remimazolam is a novel sedative that has shown potential for anti-inflammatory effects. However, whether remimazolam ameliorates TBI...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chang Sun, Yi Zhang, Jiahan Wang, Bailun Wang, Angran Gu, Yuelan Wang, Changping Gu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-12-01
coleção:	Journal of Neuroinflammation
Assuntos:	Remimazolam TBI-ALI ATF3 Pyroptosis
Acesso em linha:	https://doi.org/10.1186/s12974-025-03653-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!